Your browser doesn't support javascript.
loading
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking.
Shiakolas, Andrea R; Kramer, Kevin J; Johnson, Nicole V; Wall, Steven C; Suryadevara, Naveenchandra; Wrapp, Daniel; Periasamy, Sivakumar; Pilewski, Kelsey A; Raju, Nagarajan; Nargi, Rachel; Sutton, Rachel E; Walker, Lauren M; Setliff, Ian; Crowe, James E; Bukreyev, Alexander; Carnahan, Robert H; McLellan, Jason S; Georgiev, Ivelin S.
Afiliación
  • Shiakolas AR; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kramer KJ; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Johnson NV; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Wall SC; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Suryadevara N; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
  • Wrapp D; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Periasamy S; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Pilewski KA; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Raju N; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
  • Nargi R; Department of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • Sutton RE; Galveston National Laboratory, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • Walker LM; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Setliff I; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Crowe JE; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Bukreyev A; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Carnahan RH; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • McLellan JS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Georgiev IS; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Nat Biotechnol ; 40(8): 1270-1275, 2022 08.
Article en En | MEDLINE | ID: mdl-35241839
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Nat Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos